Global Custom Market Research Reports Provider Company

phone

DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Jul 2018
  • Number of Pages: 58
  • Category: SWOT Analysis
  • Country: Italy
DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The companys products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin SpA Key Recent Developments

Jun 12,2018: Diasorin Introduces Primer Pair Reagents For Use In Molecular Testing: Anaplasma Phagocytophilum, Ehrlichia And Babesia
Jun 12,2018: DiaSorin Molecular Introduces Primer Pair Reagents for A. phagocytophilum, Ehrlichia and Babesia
May 08,2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018
Jan 10,2018: Qiagen to offer TB diagnostic test on DiaSorins analysers
Nov 09,2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
DiaSorin SpA - Key Facts 6
DiaSorin SpA - Key Employees 7
DiaSorin SpA - Key Employee Biographies 8
DiaSorin SpA - Major Products and Services 9
DiaSorin SpA - History 10
DiaSorin SpA - Company Statement 14
DiaSorin SpA - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 17
Company Overview 17
DiaSorin SpA - Business Description 18
Geographical Segment: Europe 18
Target Markets 18
Performance 18
Geographical Segment: Italy and UK Branch 18
Performance 18
Geographical Segment: North America 19
Target Markets 19
Performance 19
Geographical Segment: Rest of the World 19
Target Markets 19
Performance 19
R&D Overview 19
DiaSorin SpA - Corporate Strategy 20
DiaSorin SpA - SWOT Analysis 21
SWOT Analysis - Overview 21
DiaSorin SpA - Strengths 21
DiaSorin SpA - Weaknesses 22
DiaSorin SpA - Opportunities 23
DiaSorin SpA - Threats 24
DiaSorin SpA - Key Competitors 25
Section 3 Company Financial Ratios 26
Financial Ratios - Capital Market Ratios 26
Financial Ratios - Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios - Interim Ratios 31
Financial Ratios - Ratio Charts 32
Section 4 Companys Lifesciences Financial Deals and Alliances 33
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
DiaSorin SpA, Medical Equipment, Deals By Type, 2012 to YTD 2018 34
DiaSorin SpA, Recent Deals Summary 35
Section 5 Companys Recent Developments 36
Jun 12, 2018: Diasorin Introduces Primer Pair Reagents For Use In Molecular Testing: Anaplasma Phagocytophilum, Ehrlichia And Babesia 36
Jun 12, 2018: DiaSorin Molecular Introduces Primer Pair Reagents for A. phagocytophilum, Ehrlichia and Babesia 37
May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 38
Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 41
Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 42
Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 43
Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 46
Jun 26, 2017: Diasorin Presents Its 2017-2019 Industrial Plan 47
May 08, 2017: Diasorin Group Reports Growth In Revenues And Profitability In The First Quarter 2017, Generating A Relevant Free Cash Flow 48
Mar 08, 2017: Net Profit And Cash Generation Reached Record Highs In 2016, Driven By Growth In Revenues And Profitability 50
Section 6 Appendix 54
Methodology 54
Ratio Definitions 54
About GlobalData 58
Contact Us 58
Disclaimer 58

List Of Tables

List of Tables
DiaSorin SpA, Key Facts 6
DiaSorin SpA, Key Employees 7
DiaSorin SpA, Key Employee Biographies 8
DiaSorin SpA, Major Products and Services 9
DiaSorin SpA, History 10
DiaSorin SpA, Other Locations 15
DiaSorin SpA, Subsidiaries 15
DiaSorin SpA, Key Competitors 25
DiaSorin SpA, Ratios based on current share price 26
DiaSorin SpA, Annual Ratios 27
DiaSorin SpA, Annual Ratios (Cont...1) 28
DiaSorin SpA, Annual Ratios (Cont...2) 29
DiaSorin SpA, Interim Ratios 31
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
DiaSorin SpA, Medical Equipment, Deals By Type, 2012 to YTD 2018 34
DiaSorin SpA, Recent Deals Summary 35
Currency Codes 54
Capital Market Ratios 54
Equity Ratios 55
Profitability Ratios 55
Cost Ratios 56
Liquidity Ratios 56
Leverage Ratios 57
Efficiency Ratios 57

List Of Figures

List of Figures
DiaSorin SpA, Performance Chart (2013 - 2017) 30
DiaSorin SpA, Ratio Charts 32
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 34

DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme

View Report

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports